HKSE · 1419.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 10:11 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Human Health Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 14.61% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Human Health Holdings Limited’s forward annual dividend is HK$0.03 per share, paid annual. The forward yield is 3.95% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Human Health Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating as an investment holding company, Human Health Holdings Limited delivers a comprehensive range of healthcare services across Hong Kong. Its primary care offerings encompass a wide array of services such as routine consultations, diagnostic testing, preventive health programs, minor medical interventions, immunizations, comprehensive physical examinations, health education, and occupational health guidance. Additionally, they provide Traditional Chinese Medicine, work injury assessments, telemedicine, COVID-19 specific services, community outreach, and various health-related products and solutions. The company extends its expertise to numerous specialized medical fields, including general surgery, orthopedics and traumatology, ophthalmology, otorhinolaryngology, pediatrics, obstetrics and gynecology, gastroenterology and hepatology, respiratory medicine, cardiology, pediatric surgery, dermatology and venereology, psychiatry, radiology, urology, nephrology, neurosurgery, anaesthesiology, and oncology. Complementing these are allied health services like physiotherapy, clinical psychology, medical aesthetics, nutritional counseling, health and wellness programs, endoscopy, and advanced medical diagnostics. Furthermore, a full spectrum of dental care is available, ranging from general dentistry, dental implants (including 3D guided surgery), crowns, bridges, and periodontal treatments, to prosthodontics, oral surgery, orthodontics, and endodontics. Cosmetic options like teeth whitening, veneers, and laser dentistry are also provided, alongside advanced oral and maxillofacial surgery, CAD/CAM technology, panoramic radiography, and cone-beam CT scans. Beyond direct patient care, the company manages agreements for healthcare practitioners and offers essential medical imaging services. Established in 1997 and headquartered in Kowloon, Hong Kong, Human Health Holdings Limited maintained a network of 58 medical centers and 103 service points as of June 30, 2021. It operates as a subsidiary of Treasure Group Global Limited.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:36 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$1.57-HK$0.01 (-0.32%)
Mediwelcome Healthcare Management & Technology Inc.’s quoted price sits in the lower half of its reported 52-week range, 30.84% below the high.
HK$0.50+HK$0.02 (+3.09%)
Kato (Hong Kong) Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 7.41% below the high.
HK$0.26HK$0.00 (0.0%)
China Health Group Limited’s quoted price sits in the lower half of its reported 52-week range, 69.77% below the high.
HK$0.37HK$0.00 (0.0%)
UMP Healthcare Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 27.0% below the high.
HK$0.38-HK$0.01 (-2.6%)
Kingworld Medicines Group Limited’s quoted price sits in the lower half of its reported 52-week range, 51.92% below the high.
HK$0.57HK$0.00 (0.0%)
Arts Optical International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 48.18% below the high.
HK$0.41-HK$0.02 (-4.71%)
Bamboos Health Care Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 30.17% below the high.
HK$1.46-HK$0.07 (-4.58%)
Qinghai Biotech Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 86.67% below the high.
